Evaluating Retention Rates in a Medication-Assisted Treatment Program

被引：3

作者：

Rioux, Jennifer ^{[1
]}

Cuellar, Norma ^{[1
]}

Oliver, JoAnn ^{[1
]}

Hsu, Powen ^{[2
]}

Szapkiw, Amanda

机构：

[1] Univ Alabama, Capstone Coll Nursing, Tuscaloosa, AL 35401 USA

[2] Tufts Univ, New Era Med, Boston, MA 02111 USA

来源：

JNP-JOURNAL FOR NURSE PRACTITIONERS | 2020年 / 16卷 / 09期

关键词：

medication-assisted treatment; opioid agonist therapy; opioid replacement therapy; opioid use disorder;

D O I：

10.1016/j.nurpra.2020.06.028

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

Only a few medications are available for the treatment of opioid use disorder (OUD), and few data exist regarding which medication is more likely to increase retention in a substance use treatment program. Findings from a retrospective review of an opioid use treatment program revealed an increase in retention rates for those receiving injectable buprenorphine extended-release (Sublocade) over those receiving transmucosal buprenorphine tablets/films (Suboxone). Because fatal opioid overdoses now lead the United States in injury-related deaths, it is imperative to provide data to health care providers that can help guide effective prescribing to save lives. (c) 2020 Elsevier Inc. All rights reserved.

引用

页码：E149 / E151

页数：3

共 50 条

[41] In Fighting An Opioid Epidemic, Medication-Assisted Treatment Is Effective But Underused
Vestal, Christine
HEALTH AFFAIRS, 2016, 35 (06) : 1052 - 1057
[42] Treatment Retention Satisfaction, and Therapeutic Progress for Justice-Involved Individuals Referred to Community-Based Medication-Assisted Treatment
Yang, Yang
Gray, Julie
Joe, George W.
Flynn, Patrick M.
Knight, Kevin
SUBSTANCE USE & MISUSE, 2019, 54 (09) : 1461 - 1474
[43] EVALUATING ALCOHOL USE OUTCOMES WITHIN THE CONTEXT OF OUTPATIENT MEDICATION-ASSISTED TREATMENT FOR OPIATE USE DISORDER (OUD)
Moskal, D.
DeFlavio, J.
Cooper, J. S.
Sneathen, B.
Connors, G. J.
Maisto, S. A.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2020, 44 : 159 - 159
[44] Medication-assisted therapy for opioid addiction
Tai, Betty
Saxon, Andrew J.
Ling, Walter
JOURNAL OF FOOD AND DRUG ANALYSIS, 2013, 21 : S13 - S15
[45] ENDING THE OPIOID EPIDEMIC REQUIRES A HISTORIC INVESTMENT IN MEDICATION-ASSISTED TREATMENT
Saloner, Brendan
Barry, Colleen L.
JOURNAL OF POLICY ANALYSIS AND MANAGEMENT, 2018, 37 (02) : 431 - 438
[46] Prisoners as Patients: The Opioid Epidemic, Medication-Assisted Treatment, and the Eighth Amendment
Linden, Michael
Marullo, Sam
Bone, Curtis
Barry, Declan T.
Bell, Kristen
JOURNAL OF LAW MEDICINE & ETHICS, 2018, 46 (02): : 252 - 267
[47] National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment
Jones, Christopher M.
Campopiano, Melinda
Baldwin, Grant
McCance-Katz, Elinore
AMERICAN JOURNAL OF PUBLIC HEALTH, 2015, 105 (08) : E55 - E63
[48] MEDICATION-ASSISTED TREATMENT FOR OPIOID DEPENDENCE: A CLAIMS-BASED ANALYSIS
Lu, Y.
Leslie, D. L.
VALUE IN HEALTH, 2016, 19 (03) : A193 - A194
[49] Do Federal Grants for Medication-Assisted Opioid Treatment Reduce Homelessness?
Sullivan, Andrew
Park, Changwe
ANNALS OF THE AMERICAN ACADEMY OF POLITICAL AND SOCIAL SCIENCE, 2022, 703 (01): : 285 - 302
[50] Lived experiences of Oxford House residents prescribed medication-assisted treatment
Soto-Nevarez, Arturo
Abo, Mary
Hudson, Mackenzie
Bobak, Ted
Jason, Leonard A. A.
JOURNAL OF COMMUNITY PSYCHOLOGY, 2023, 51 (07) : 2828 - 2844

← 1 2 3 4 5 →